REAL-WORLD USE OF TAFASITAMAB FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES BY PRIMARY REFRACTORY STATUS K Saverno; KMZ Savill; B Feinberg; J Galvin; P Pathak; T Amoloja; N Epperla; LJ Nastoupil;

REAL-WORLD USE OF TAFASITAMAB FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES BY AGE GROUP (> 70 YEARS AND 70 YEARS) N Epperla; LJ Nastoupil; KMZ Savill; B Feinberg; J Galvin; P Pathak; T Amoloja; M Vukcevic; K Saverno;